Paid Clinical Trials Newark

Discover 1,571 paid clinical trials in Newark, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,571

Enstilar & EnbrelEnstilar in Combination With Enbrel or Humira for Plaque Psoriasis

Recruiting

Sponsor:

Psoriasis Treatment Center of Central New Jersey

Location:

East Windsor NJ

Code:

NCT03827876

Conditions

Psoriasis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Enstilar 0.005%-0.064% Topical Foam

Lomustine with Temozolomide & RadiationTesting the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma

Recruiting

PHASE3

Sponsor:

NRG Oncology

Location:

Newark NJ, Livingston NJ, New York NY, New Brunswick NJshow 269 more

Code:

NCT05095376

Conditions

Glioblastoma

Gliosarcoma

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

Lomustine

Magnetic Resonance Imaging

Photon Beam Radiation Therapy

Questionnaire Administration

Temozolomide

Mezigdomide & CarfilzomibA Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2)

Recruiting

PHASE3

Sponsor:

Bristol-Myers Squibb

Location:

Bronx NY, Little Silver NJ, Newark DE, Providence RIshow 34 more

Code:

NCT05552976

Conditions

Relapsed or Refractory Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Mezigdomide

Carfilzomib

Dexamethasone

CLN-619 & PembrolizumabA Study of CLN-619 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors

Recruiting

PHASE1

Sponsor:

Cullinan Therapeutics Inc.

Location:

New York NY, Hackensack NJ, Boston MA, Fairfax VAshow 8 more

Code:

NCT05117476

Conditions

Advanced Solid Tumor

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

CLN-619

Pembrolizumab

Blood Pressure ControlA Study of Blood Pressure Control During Cancer Treatment

Recruiting

PHASE2

Sponsor:

Memorial Sloan Kettering Cancer Center

Location:

New York NY, Basking Ridge NJ, Montvale NJ, Middletown NJshow 3 more

Code:

NCT06023576

Conditions

Breast Cancer

Cardiotoxicity

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

antihypertensive medications

Blood pressure measurement

Echocardiogram

Symptom-limited cardiopulmonary exercise test

Quality of Life Measures

AtogepantA Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine

Recruiting

PHASE3

Sponsor:

AbbVie

Location:

New York NY, Morristown NJ, Amherst NY, Franklin VAshow 35 more

Code:

NCT05711394

Conditions

Episodic Migraine

Eligibility Criteria

Sex: All

Age: 6 - 17

Healthy Volunteers: Not accepted

Interventions

Atogepant

Placebo-Matching Atogepant

Amnioband vs. Standard of CareAmnioband and Standard of Care vs. Standard of Care Alone in the Treatment of Venous Leg Ulcers

Recruiting

Sponsor:

SerenaGroup, Inc.

Location:

Brick NJ, Elmer NJ, Boston MA, Kittanning PAshow 4 more

Code:

NCT02609594

Conditions

Venous Leg Ulcers

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Weekly application of Amnioband

Biweekly application of Amnioband

Standard of Care

Cema-celConsolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

Recruiting

PHASE2

Sponsor:

Allogene Therapeutics

Location:

New York NY, Hackensack NJ, New Brunswick NJ, East Brunswick NJshow 33 more

Code:

NCT06500273

Conditions

Large B-cell Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

cemacabtagene ansegedleucel

ALLO-647

Fludarabine

Cyclophosphamide

Foresight CLARITY™ IUO MRD test, powered by PhasED-Seq™

AP-CD/LDA Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004

Recruiting

PHASE3

Sponsor:

Intec Pharma Ltd.

Location:

New York NY, Summit NJ, Commack NY, Vernon CTshow 32 more

Code:

NCT02615873

Conditions

Parkinson's Disease

Eligibility Criteria

Sex: All

Age: 30 - 70+

Healthy Volunteers: Not accepted

Interventions

Accordion Pill™ Carbidopa/Levodopa

PembrolizumabLong-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

Recruiting

PHASE3

Sponsor:

Merck Sharp & Dohme LLC

Location:

New York NY, Hackensack NJ, New Brunswick NJ, White Plains NYshow 68 more

Code:

NCT03486873

Conditions

Solid Tumors

Hematologic Malignancies

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Pembrolizumab

Standard of Care (SOC)

Lenvatinib

Olaparib

MK-4280